Stockreport

Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases [Yahoo! Finance]

Ventyx Biosciences, Inc.  (VTYX) 
PDF Acquisition builds on Lilly's established capabilities in inflammatory-mediated diseases INDIANAPOLIS Jan. 7, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) a [Read more]